SUPN
Supernus Pharmaceuticals Inc
NASDAQ: SUPN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$48.55
-0.29% today
Updated 2026-04-29
Market cap
$2.80B
P/E ratio
—
P/S ratio
3.89x
EPS (TTM)
$-0.68
Dividend yield
—
52W range
$29 – $60
Volume
0.7M
Supernus Pharmaceuticals Inc (SUPN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.98M | $-29.65M | $2.63M | $-32.54M | $-36.19M | $-47.20M | $-57.95M | $7.73M | $32.12M | $66.81M | $114.64M | $128.99M | $143.13M | $138.40M | $127.13M | $116.83M | $111.08M | $171.95M | $47.33M |
| Capital expenditures | $1.06M | $135000.00 | $714000.00 | $294000.00 | $685000.00 | $753000.00 | $2.35M | $593000.00 | $2.10M | $1.60M | $2.03M | $844000.00 | $2.74M | $3.45M | $2.04M | $412000.00 | $551000.00 | $725000.00 | $1.34M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $74100.00 | $99000.00 | $111000.00 | $297000.00 | $-82000.00 | $443000.00 | $1.91M | $2.72M | $4.23M | $5.93M | $8.43M | $11.29M | $14.85M | $16.56M | $17.91M | $17.57M | $26.76M | $27.75M | $33.05M |
| Free cash flow | $-15.04M | $-29.79M | $1.92M | $-32.84M | $-36.87M | $-47.95M | $-60.30M | $7.14M | $30.02M | $65.21M | $112.61M | $128.14M | $140.39M | $134.95M | $125.08M | $116.41M | $110.53M | $171.23M | $45.99M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-8.24M | $-7.32M | $3.42M | $-2.90M | $32.90M | $33.91M | $91.94M | $-10.87M | $107.26M | $-85.21M | $-110.31M | — | — | — |